Side effects and complications. Tesamorelin--results from Phase III.
D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D013007:Growth Hormone-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D019562:Viral Load
D010919:Placebos; D013007:Growth Hormone-Releasing Hormone; C479538:tesamorelin